Literature DB >> 25126252

Chronic obstructive pulmonary disease: an overview.

John F Devine1.   

Abstract

Chronic obstructive pulmonary disease is a growing healthcare problem that is expected to worsen as the population ages and the worldwide use of tobacco products increases. Smoking cessation is the only effective means of prevention. Employers are in a unique position to help employees stop smoking. During the long asymptomatic phase, lung function nevertheless continues to decline; therefore, many patients seek medical attention only when they are at an advanced stage or when they have experienced an acute exacerbation. To help preserve patients' quality of life and reduce healthcare costs related to this chronic disease, clinicians need to accurately diagnose the condition and appropriately manage patients through the long course of their illness. This article discusses the current approach to patient management.

Entities:  

Year:  2008        PMID: 25126252      PMCID: PMC4106574     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  36 in total

1.  Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.

Authors:  E J Wagena; M J Huibers; C P van Schayck
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 2.  Management of chronic obstructive pulmonary disease.

Authors:  E Rand Sutherland; Reuben M Cherniack
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

3.  "Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice.

Authors:  D H Wilson; M A Wakefield; I D Steven; R A Rohrsheim; A J Esterman; N M Graham
Journal:  Med J Aust       Date:  1990-05-21       Impact factor: 7.738

4.  Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.

Authors:  Keith S Naunheim; Douglas E Wood; Zab Mohsenifar; Alice L Sternberg; Gerard J Criner; Malcolm M DeCamp; Claude C Deschamps; Fernando J Martinez; Frank C Sciurba; James Tonascia; Alfred P Fishman
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

7.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

Review 8.  Chronic obstructive pulmonary disease . 7: Management of COPD.

Authors:  W MacNee; P M A Calverley
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

9.  Smoking and lung function of Lung Health Study participants after 11 years.

Authors:  Nicholas R Anthonisen; John E Connett; Robert P Murray
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

10.  Sputum analysis in diagnosis and management of obstructive airway diseases.

Authors:  Paige Lacy; Jennifer L Lee; Dilini Vethanayagam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

View more
  11 in total

1.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial.

Authors:  Mohammadali Saba; Abdoulhossein Davoodabadi; Azin Ghaffari; Hamidreza Gilasi; Babak Haghpanah
Journal:  Ann Med Surg (Lond)       Date:  2020-07-18

3.  Distinct Exosomal miRNA Profiles from BALF and Lung Tissue of COPD and IPF Patients.

Authors:  Gagandeep Kaur; Krishna Prahlad Maremanda; Michael Campos; Hitendra S Chand; Feng Li; Nikhil Hirani; M A Haseeb; Dongmei Li; Irfan Rahman
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

Review 4.  TGF-β: The missing link in obesity-associated airway diseases?

Authors:  Joanna Woo; Cynthia Koziol-White; Reynold Panettieri; Joseph Jude
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-02-05

5.  The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease.

Authors:  Je-Oh Lim; Woong-Il Kim; Se-Jin Lee; So-Won Pak; Young-Kwon Cho; Jong-Choon Kim; Joong-Sun Kim; In-Sik Shin
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

Review 6.  Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?

Authors:  Paolo Solidoro; Carlo Albera; Fulvia Ribolla; Michela Bellocchia; Luisa Brussino; Filippo Patrucco
Journal:  Front Med (Lausanne)       Date:  2022-03-23

7.  Characteristics and outcomes of diabetic patients with acute exacerbation of COPD.

Authors:  Elio Monsour; Lyd-Marie Rodriguez; Randa Abdelmasih; Kubra Tuna; Khalid Abusaada
Journal:  J Diabetes Metab Disord       Date:  2021-04-23

8.  Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke.

Authors:  Lukasz Czekala; Roman Wieczorek; Liam Simms; Fan Yu; Jessica Budde; Edgar Trelles Sticken; Kathryn Rudd; Thomas Verron; Oleg Brinster; Matthew Stevenson; Tanvir Walele
Journal:  Curr Res Toxicol       Date:  2021-02-20

Review 9.  Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.

Authors:  Bassam H Mahboub; Mayank Gian Vats; Ashraf Al Zaabi; Mohammed Nizam Iqbal; Tarek Safwat; Fatma Al-Hurish; Marc Miravitlles; Dave Singh; Khaled Asad; Salah Zeineldine; Mohamed S Al-Hajjaj
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-09

10.  FEF25-75% Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Do Sun Kwon; Yong Jun Choi; Tae Hee Kim; Min Kwang Byun; Jae Hwa Cho; Hyung Jung Kim; Hye Jung Park
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.